Earl Bakken, the founder of Medtronic, tells employees he's behind the company's $43 billion acquisition of Covidien and its potential to save a life every second.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/VrZgFq
Cap comentari:
Publica un comentari a l'entrada